Sandoz
Sandoz is a global pharmaceutical company specializing in generic medicines and biosimilars. Founded in 1886, it was previously part of Novartis but became an independent company in 2023. Sandoz plays a key role in providing high-quality and affordable medicines to millions of patients worldwide.
Overview
CEO: Richard Saynor
Company Overview:
At Sandoz, we take pride in our legacy of innovation and leadership in healthcare. With roots dating back to 1886, Sandoz has played a crucial role in biosimilars, generic antibiotics, and other essential medicines.
Historical Milestones:
🔹 1886 – Founded as Kern & Sandoz in Basel, Switzerland, originally focused on synthetic dyes. Later transitioned to pharmaceuticals.
🔹 1929 – Launched Calcium Sandoz, a major breakthrough in treating calcium deficiency.
🔹 1939 – Officially adopted the Sandoz name.
🔹 1946 – Developed the world’s first-ever oral penicillin, solidifying its position in antibiotic production.
🔹 1980 – Introduced recombinant proteins, now used in vaccines, hormones, and enzymes.
🔹 1996 – Merged with Ciba-Geigy to form Novartis, making Sandoz dormant until 2003.
🔹 2006 – Became the first company to receive biosimilar approval in Europe.
🔹 2015 – Launched Zarxio® (filgrastim), the first biosimilar approved in the US.
🔹 2023 – Sandoz became independent from Novartis, reinforcing its focus on biosimilars and generics.
Today, Sandoz is the world’s largest producer of generic antibiotics and continues to lead in biosimilars and affordable healthcare solutions.
Website
https://www.sandoz.com/Address
Sandoz AG Centralbahnstrasse 4 4051 Basel Switzerland.Contact
-
Recent products
Hyrimoz
5 months ago
Recommended Companies
